The designation follows a period of significant strain on diagnostic workflows. A study from the Neiman Health Policy Institute revealed that outpatient imaging turnaround times more than doubled between 2014 and 2023. In emergency departments, these delays can add up to 150 minutes to a patient’s stay, complicating clinical decision-making. First Read is engineered to mitigate these bottlenecks by automating draft text generation, allowing physicians to focus on higher-value clinical judgment.
Aidoc Secures FDA Breakthrough Status for AI Radiology Reporting
The U.S. Food and Drug Administration has granted Breakthrough Device Designation to First Read, an AI tool from Aidoc designed to generate preliminary radiology reports for chest radiographs. This move aims to alleviate the mounting pressure on radiologists as imaging demand continues to outpace current clinical capacity worldwide.

Built on the same architecture as Aidoc's established CARE foundation model, the system is currently deployed across nearly 2,000 hospitals, including major systems like Sutter Health and Mercy. While generative AI in medical reporting carries inherent risks regarding accuracy and legal liability, Aidoc emphasizes that this tool is designed to support, rather than replace, clinician oversight. CEO Elad Walach noted that the technology seeks to absorb operational burdens that have historically outstripped the capacity of traditional radiology tools. The company, which recently closed a $150 million Series E round, continues to scale its aiOS platform as it seeks to address the widening gap between imaging volume and available diagnostic expertise.



Comments (0)
No comments yet. Be the first!